// App-Quantinova.ai

: A Multicenter Randomized Study in Early Rheumatoid Arthritis to Compare Active Conventional Therapy versus Three Biological Treatments: 24 Week Efficacy and Safety Results of the NORD-STAR Trial

Researchers

Presenter

  • Espen A Haavardsholm

Principal Investigators

  • Dan Nordstrom

  • Mike Nurmohamed

  • Bjorn Gudbjornsson

  • Jon Lampa

  • Kim Harslev-Petersen

  • Till Uhlig

  • Gerdur Grondal

  • Mikkel astergaard

  • Marte Heiberg

  • Jos Twisk

  • Kristina Lend

  • Simon Krabbe

  • Joakim Lindqvist

  • Anna-Karin Ekwall

  • Kathrine Lederballe Gran

  • Meliha Kapetanovic

  • Francesca Faustini

  • Riitta Tuompo

  • Tove Lorenzen

  • Giovanni Cagnotto

  • Eva Baecklund

  • Oliver Hendricks

  • Daisy Vedder

  • Tuulikki Sokka-isler

  • Tomas Husmark

  • Maud-Kristine Aga Ljosa

  • Eli Brodin

  • Torkell Ellingsen

  • Annika Soderbergh

  • Milad Rizk

  • asa Reckner

  • Line Uhrenholt

  • Per Larsson

  • Soeren Just

  • David Stevens

  • Trine Laurberg

  • Gunnstein Bakland

  • Inge Christoffer Olsen

  • Ronald van Vollenhoven

Medical Centers

  • DANBIO and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Rigshospitalet, Copenhagen, Denmark

  • Diakonhjemmet Hospital, Oslo, Norway

  • Dept. of Rheumatology and Inflammation Research, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden

  • Department of Medicine, ROB-FIN, Helsinki University Hospital and Helsinki University, Helsinki, Finland., Helsinki, Finland

  • Amsterdam Rheumatology and immunology Center location Amsterdam UMC location VU medical center, Amsterdam, Netherlands Antilles

  • Centre for Rheumatology Research, Landspitali and Faculty of Medicine, University of Iceland, Reykjavik, Iceland

  • Karolinska Institutet, Stockholm, Sweden

  • Department of Rheumatology, King Christian X's Hospital for Rheumatic Diseases Graasten, Denmark, Graasten, Denmark

  • Diakonhjemmet Hospital, Dept. of Rheumatology / University of Oslo, Faculty of Medicine, Oslo, Norway

  • Department of Rheumatology, Landspitali and Centre for Rheumatology Research, Landspitali, Reykjavík, Iceland

  • Copenhagen Center for Arthritis Research, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark

  • Department of Epidemiology and Biostatistics, VUmc, Amsterdam, Netherlands.

  • Rigshospitalet, København, Denmark

  • University of Gothenburg, Kullavik, Sweden

  • Rigshospitalet Glostrup Glostrup Denmark

  • Lund University, Skane University Hospital, Department of Clinical Sciences Lund, Section of Rheumatology, Lund and Malmö, Sweden, Lund, Sweden

  • Helsinki University Hospital, Helsinki, Finland

  • Reumatologi, Regionshospitalet Silkeborg, Kolding, Denmark

  • Lund University, Malmo, Sweden

  • Uppsala University Hospital, Uppsala, Sweden

  • Danish Hospital for Rheumatic Diseases, Sønderborg, Denmark

  • Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands

  • Jyvaskyla Central Hospital, Jyvaskyla, Finland

  • Rheumatology Clinic, Falun, Sweden

  • Ã…lesund Hospital Helse Møre og Romsdal HF, Ã…lesund, Norway

  • Haukeland University Hospital, Bergen, Norway

  • Department of Oncology, Odense University Hospital, Odense, Denmark

  • xcurebro University Hospital, xcurebro, Sweden

  • Västmanlands Hospital, VästerÃ¥s, Sweden

  • Rheumatology Department, Linkoping, Sweden

  • Aalborg Universitets Hospital, Aalborg, Denmark

  • Center for Rheumatology, Academic Specialist Center, Stockholm Health Services, Stockholm, Sweden, Stockholm, Sweden

  • Odense University Hospital, Odense, Denmark

  • St. Olav's University Hospital, Trondheim, Norway

  • Aarhus University Hospital, Aarhus, Denmark

  • University Hospital of North Norway, Tromso, Norway

  • Oslo University Hospital, Oslo, Norway

  • Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands

  • Site investigators in all participating countries, Stockholm, Sweden

Locations

  • Denmark

  • Norway

  • Sweden

  • Finland

  • Netherlands

  • Iceland

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

  • STAR syndrome

Biomarkers

  • C reactive protein

  • Body mass index

  • Albumin/creatinine

Drug/Treatment

  • Triamcinolone Hexacetonide

  • Hydroxychloroquine

  • sulphasalazine

  • Triamcinolone acetonide

  • Certolizumab pegol

  • Methotrexate

  • Prednisolone

  • Tocilizumab

  • Abatacept

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

  • Open Label

  • Non Inferiority

  • Multicenteric

Phase

  • IV

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved